US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 7.190
  • -0.190-2.57%
Close Dec 3 16:00 ET
  • 7.200
  • +0.010+0.14%
Post 20:01 ET
1.49BMarket Cap-11786P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioCryst Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 4, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
112.67M
117.09M
+4.42M
Beat Est.
+29.89%
+34.98%
+3.92%
EPS
-0.08
-0.07
+<0.01
Beat Est.
+58.61%
+63.16%
+10.94%
Analyst Rating
Strong Buy

Dec 3, 2024

BioCryst Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 117.500M--
--2024/Q4-- / 127.719M--
Nov 4, 20242024/Q3117.085M / 112.666M--
Aug 5, 20242024/Q2109.332M / 98.324M--
May 6, 20242024/Q192.761M / 85.505M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 117.500M--
--2024/Q4-- / 127.719M--
Nov 4, 20242024/Q3117.085M / 112.666M--
Aug 5, 20242024/Q2109.332M / 98.324M--
May 6, 20242024/Q192.761M / 85.505M--

Unlock Free Earnings Estimates

BioCryst Pharmaceuticals Earnings Reports

  • BioCryst Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 5 17:21 ET

  • BioCryst Pharmaceuticals | 8-K: BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 4 07:09 ET

  • BioCryst Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:09 ET

  • BioCryst Pharmaceuticals | 8-K: BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 5 07:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 3, 2024

    Strong Buy

    • Buy

      88.89%

    • Hold

      11.11%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data